A Longitudinal, Retrospective, Multi-centre Observational Study to Evaluate Effectiveness, Persistence, Treatment Patterns and Safety of Australian Patients Receiving Early Access to Tofacitinib

29/11/2021
26/11/2025
EU PAS number:
EUPAS41439
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A3921405 final approved protocol

English (2.47 MB - PDF) View document
Updated protocol

A3921405_Non-Interventional Study Protocol (REDACTED)_V3.0_15AUG2024.pdf

First published: 26/09/2024
English (522.34 KB - PDF) View document
Study results
Study results

A39214~2.PDF

English (239.22 KB - PDF) View document
Study report
Study report

A39214~2.PDF

English (239.22 KB - PDF) View document
Other information
Study, other information

A3921405 Non Interventional Study Abstract V2.0 23 September 2021_Redacted

English (1.33 MB - PDF) View document

A3921405 Non-Interventional Protocol Study Abstract 26 May 2021_

English (79.68 KB - PDF) View document